US Expanded Access Program for Magrolimab in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT05627466 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT05627466
- Sponsor
- Gilead Sciences
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.